Basic Information
Basic information for SOX2-OT-268-16aa-2
Peptide Name SOX2-OT-268-16aa-2
Genome Position chr3:181741093-181741140[+]
Species Human
Peptide Sequence MDLISKLIILKEKWRY
Peptide Length 16
Unique No (SOX2-OT-207-16aa-2,SOX2-OT-213-16aa-2,SOX2-OT-218-16aa-2,SOX2-OT-225-16aa-2,SOX2-OT-231-16aa,SOX2-OT-234-16aa-2,SOX2-OT-261-16aa-2,SOX2-OT-276-16aa-3,SOX2-OT-280-16aa-2,SOX2-OT-283-16aa-3,SOX2-OT-285-16aa-3,SOX2-OT-287-16aa-2,SOX2-OT-291-16aa-3,SOX2-OT-292-16aa-2,SOX2-OT-293-16aa-3,SOX2-OT-294-16aa-2,SOX2-OT-295-16aa-2,SOX2-OT-296-16aa-3,SOX2-OT-297-16aa-3,SOX2-OT-298-16aa-2,SOX2-OT-299-16aa-2,SOX2-OT-300-16aa-2,SOX2-OT-301-16aa-2,SOX2-OT-303-16aa-2,SOX2-OT-304-16aa-2)
Grand Average of Hydropathicity 0.0375
Relative Molecular Mass 2319.73
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000643236;SOX2-OT-268
Transcript Length 2454
Coding Ability 0.3468
DNA Sequence Corresponding to Peptide ATGGATCTTATTTCAAAGTTGATTATTCTCAAAGAAAAGTGGAGATAT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :